Exchange: NASDAQ·Updated 04:00 AM EDT
ATAI logo

ATAI AtaiBeckley Inc.

$7.44
$0.00
(0.00%)
Pre-Market
Prev Close $7.44
EarningsNov 12
Mkt Cap$2.74B
Vol135.00

About ATAI

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.
62

Bullish Sentiment

How do you feel about ATAI?

Advertisement|Remove ads.